112
Views
14
CrossRef citations to date
0
Altmetric
Research Article

PREDICTING DRUG INTERACTIONS AND PHARMACOKINETIC VARIABILITY WITH IN VITRO METHODS: THE OLANZAPINE EXPERIENCE*

&
Pages 15-28 | Published online: 02 Aug 1999

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Sakuda, T. Akabane & T. Teramura. (2006) Marked species differences in the bioavailability of midazolam in cynomolgus monkeys and humans. Xenobiotica 36:4, pages 331-340.
Read now

Articles from other publishers (13)

Nevena Todorović Vukotić, Jelena Đorđević, Snežana Pejić, Neda Đorđević & Snežana B. Pajović. (2021) Antidepressants- and antipsychotics-induced hepatotoxicity. Archives of Toxicology 95:3, pages 767-789.
Crossref
Başak Togar, Hasan Turkez, Abdulgani Tatar, Ismet Kırkpınar, Ahmet Hacımuftuoglu, Fatime Geyikoglu, M Sait Keles & Ebubekir Dirican. (2011) The genotoxic potentials of some atypical antipsychotic drugs on human lymphocytes. Toxicology and Industrial Health 28:4, pages 327-333.
Crossref
Hasan T?rkez & Ba?ak To?ar. (2010) The genotoxic and oxidative damage potential of olanzapine in vitro. Toxicology and Industrial Health 26:9, pages 583-588.
Crossref
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development 55 107 .
Esther M. van der Zwaal, Mieneke C.M. Luijendijk, Roger A.H. Adan & Susanne E. la Fleur. (2008) Olanzapine-induced weight gain: Chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution. European Journal of Pharmacology 585:1, pages 130-136.
Crossref
Chin B. Eap, Stefan Bender, Eveline Jaquenoud Sirot, Gianni Cucchia, Michèle Jonzier-Perey, Pierre Baumann, Delphine Allorge & Franck Broly. (2004) Nonresponse to Clozapine and Ultrarapid CYP1A2 Activity. Journal of Clinical Psychopharmacology 24:2, pages 214-219.
Crossref
Juan Antonio Carrillo, Angustias G. Herr?iz, Sara Isabel Ramos, Guillermo Gervasini, Sonia Vizca?no & Julio Ben?tez. (2003) Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine. Journal of Clinical Psychopharmacology 23:2, pages 119-127.
Crossref
Megan A Gibbs & Natilie A Hosea. (2003) Factors Affecting the Clinical Development of Cytochrome P450 3A Substrates. Clinical Pharmacokinetics 42:11, pages 969-984.
Crossref
Kristian Linnet & Ole V. Olesen. (2002) Free and Glucuronidated Olanzapine Serum Concentrations in Psychiatric Patients: Influence of Carbamazepine Comedication. Therapeutic Drug Monitoring 24:4, pages 512-517.
Crossref
Kristian Linnet. (2002) Glucuronidation of olanzapine by cDNA‐expressed human UDP‐glucuronosyltransferases and human liver microsomes. Human Psychopharmacology: Clinical and Experimental 17:5, pages 233-238.
Crossref
Yoshie Hirano, Mayumi Uehara, Ken-ichi Saeki, Taka-aki Kato, Kazuhiko Takahashi & Takaharu Mizutani. (2002) The Influence of Quinolines on Coumarin 7-Hydroxylation in Bovine Liver Microsomes and Human CYP2A6.. Journal of Health Science 48:2, pages 118-125.
Crossref
Heidi L. Liston, John S. Markowitz & C. Lindsay DeVane. (2001) Drug Glucuronidation in Clinical Psychopharmacology. Journal of Clinical Psychopharmacology 21:5, pages 500-515.
Crossref
Silvio Caccia. (2000) Biotransformation of Post-Clozapine Antipsychotics. Clinical Pharmacokinetics 38:5, pages 393-414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.